These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9104904)

  • 41. Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
    Wu C; Tcherny-Lessenot S; Dai W; Wang Y; Kechemir H; Gandhi S; Lin S; Juhaeri J
    Clin Ther; 2018 Mar; 40(3):450-455.e1. PubMed ID: 29500139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical challenge. I: Control of recurrent symptomatic atrial fibrillation.
    Reimold SC
    Eur Heart J; 1996 Jul; 17 Suppl C():35-40. PubMed ID: 8809537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
    Mooss AN; Wurdeman RL; Sugimoto JT; Packard KA; Hilleman DE; Lenz TL; Rovang KS; Arcidi JM; Mohiuddin SM
    Am Heart J; 2004 Oct; 148(4):641-8. PubMed ID: 15459595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the cost-effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia.
    Tesic D; Kostic M; Paunovic D; Jankovic SM
    Kardiol Pol; 2015; 73(4):287-95. PubMed ID: 25428811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.
    Dorian P; Paquette M; Newman D; Green M; Connolly SJ; Talajic M; Roy D
    Am Heart J; 2002 Jun; 143(6):984-90. PubMed ID: 12075253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amiodarone versus Sotalol and Propafenone for prevention of immediate recurrence of atrial fibrillation after internal cardioversion: importance of P wave analysis.
    Gorenek B; Cavusoglu Y; Goktekin O; Birdane A; Kudaiberdieva G; Ata N; Unalir A; Timuralp B
    Int J Cardiol; 2006 Jan; 106(2):268-9. PubMed ID: 16321704
    [No Abstract]   [Full Text] [Related]  

  • 47. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.
    Kochiadakis GE; Igoumenidis NE; Hamilos ME; Marketou ME; Chlouverakis GI; Vardas PE
    Am J Cardiol; 2007 Jun; 99(12):1721-5. PubMed ID: 17560882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial.
    Boriani G; Biffi M; Capucci A; Botto GL; Broffoni T; Rubino I; Della Casa S; Sanguinetti M; Magnani B
    Ann Intern Med; 1997 Apr; 126(8):621-5. PubMed ID: 9103129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P; Botto GL; Baldi N
    Ital Heart J Suppl; 2005 Jun; 6(6):335-40. PubMed ID: 16013424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral loading with propafenone: a placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation.
    Boriani G; Biffi M; Capucci A; Botto GL; Broffoni T; Rubino I; Della Casa S; Sanguinetti M; Branzi A; Magnani B
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2465-9. PubMed ID: 9825368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review.
    Hughes C; Sunderji R; Gin K
    Can J Cardiol; 1997 Sep; 13(9):839-42. PubMed ID: 9343033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A comparison between propafenone and hydroquinidine perorally in the treatment of recent-onset atrial fibrillation].
    Satullo G; Arrigo F; Cavallaro L; Coglitore A; Fazio F; Saporito F; Sorrenti S; Oreto G
    Minerva Cardioangiol; 1996 Mar; 44(3):141-4. PubMed ID: 8767614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.
    Bellandi F; Dabizzi RP; Cantini F; Natale MD; Niccoli L
    Cardiovasc Drugs Ther; 1996 May; 10(2):153-7. PubMed ID: 8842507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial.
    Lombardi F; Borggrefe M; Ruzyllo W; Lüderitz B;
    Eur Heart J; 2006 Sep; 27(18):2224-31. PubMed ID: 16935870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment.
    Alboni P; Botto GL; Boriani G; Russo G; Pacchioni F; Iori M; Pasanisi G; Mancini M; Mariconti B; Capucci A
    Heart; 2010 Apr; 96(7):546-9. PubMed ID: 20350992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study.
    Kochiadakis GE; Igoumenidis NE; Parthenakis FI; Chlouverakis GI; Vardas PE
    J Am Coll Cardiol; 1999 Mar; 33(4):966-71. PubMed ID: 10091823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens.
    Botto GL; Capucci A; Bonini W; Boriani G; Broffoni T; Barone P; Espureo M; Lombardi R; Molteni S; Ferrari G
    Int J Cardiol; 1997 Jan; 58(1):55-61. PubMed ID: 9021428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.